The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse cystectomy.
Enes Malik AkdaşMustafa Melih ÇulhaEngin TelliEfe BosnalıSerdar BaykalEnes Abdullah BaynalKerem TekeÖnder KaraPublished in: International urology and nephrology (2024)
Intravesical CHT-MMC can be considered as an alternative treatment in selected well-informed patients with non-muscle-invasive papillary urothelial carcinoma who are unresponsive to BCG or intolerant to BCG. Prospectively designed studies with larger number of patients are needed.